Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994

Clinical Infectious Diseases

Volumn 25, Issue 2, 1997, Pages 195-199

  Hibbs, Jonathan R ^b   Douglas Jr , John M ^b   Judson, Franklyn N ^b   McGill, William L ^b   Rietmeijer, Cornelius A M ^b   Janoff, Edward N ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; CHILD; EPIDEMIC; FEMALE; GENERAL HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PENICILLIN RESISTANCE; PREVALENCE; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINATION;

EID: 0030839052     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514538     Document Type: Article

References (27)

1. Gilks CF, Brindle RJ, Otieno LS, et al. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 1990; 336:545-9.
2. Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992; 117:314-24.
3. Redd SC, Rutherford GW III, Sande MA, et al. The role of human immuno-deficiency virus in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990; 162:1012-7.
4. Schuchat A, Broome CV, Hightower A, Costa SJ, Parkin W. Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population. JAMA 1991; 265: 3275-9.
5. Finland M. Increased resistance in the pneumococcus [editorial]. N Engl J Med 1971; 284:212-4.
6. Hofmann J, Cetron MS, Parley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333:481-6.
7. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3:171-96.
8. Centers for Disease Control. Pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep 1989; 38:64-8, 73-6.
9. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60:759-76.
10. Health and Public Policy Committee, American College of Physicians. Pneumococcal vaccine. Ann Intern Med 1986; 104:118-20.
11. Jorgensen JH, Swenson JM, Tenover FC, Ferraro MJ, Hindler JA, Murray PR. Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol 1994; 32:2448-59.
12. Krisher KK, Linscott A. Comparison of three commercial MIC systems, E test, fastidious antimicrobial susceptibility panel, and FOX fastidious panel, for confirmation of penicillin and cephalosporin resistance in Streptococcus pneumoniae. J Clin Microbiol 1994; 32:2242-5.
13. Trepka MJ, Davidson AJ, Douglas JM Jr. Extent of undiagnosed HIV infection in hospitalized patients: assessment by linkage of seroprevalence and surveillance methods. Am J Prev Med 1996; 12:195-202.
14. Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985; 41:55-68.
15. Chirurgi VA, Edelstein H, McCabe R. Pneumococcal bacteremia as a marker for human immunodeficiency virus infection in patients without AIDS. South Med J 1990; 83:895-9.
16. Janoff EN, O'Brien J, Thompson P, et al. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis 1993; 167:49-56.
17. Örtqvist Å, Kalin M, Julander I, Mufson MA. Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations - Huntington, WVa, and Stockholm, Sweden. Chest 1993; 103:710-6.
18. Cortese MM, Wolff M, Almeido-Hill J, Reid R, Ketcham J, Santosham M. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med 1992; 152:2277-82.
19. Paul J, Kimari J, Gilks CF. Streptococcus pneumoniae resistant to penicillin and tetracycline associated with HIV seropositivity [letter]. Lancet 1995: 346:1034-5.
20. Kuikka A, Syrjänen J, Renkonen OV, Valtonen VV. Pneumococcal bacteraemia during a recent decade. J Infect 1992; 24:157-68.
21. Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP, Pneumococcus Study Group. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis 1993; 168:1532-6.
22. Bennett NM, Buffington J, La Force FM. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health 1992; 82:1513-6.
23. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333:474-80.
24. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage levels among persons aged greater than or equal to 65 years - United States, 1973-1993. MMWR Morb Mortal Wkly Rep 1995:44:506-15.
25. Centers for Disease Control and Prevention. Prevalence of penicillin-resistant Streptococcus pneumoniae - Connecticut, 1992-1993. MMWR Morb Mortal Wkly Rep 1994; 43:216-7, 223.
26. Centers for Disease Control and Prevention. Emergence of penicillin-resistant Streptococcus pneumoniae - Southern Ontario, Canada, 1993-1994. MMWR Morb Mortal Wkly Rep 1995; 44:207-15.
27. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. MMWR Morb Mortal Wkly Rep 1995; 7:6.